Moreover, PD-L1 blockade promoted infiltration of tumor-reactive CD8+ T cells into established tumors in a mouse model of pancreatic cancer 43, while PD-L2 blockade decreased the numbers of tumor-infiltrating regulatory T cells 44. The gene discussed is CD8A; the disease is neoplasm.